AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction
Rabea Hinkel(German Primate Center), Christian Kupatt(München Klinik), Andrea Howe(TUM Klinikum), Victoria Jurisch(TUM Klinikum), Tarik Bozoglu(München Klinik), Thomas Thum(Medizinische Hochschule Hannover), Andrea Bähr(TUM Klinikum), Lisa Oberberger(TUM Klinikum), Alessandra Moretti(TUM Klinikum), Sándor Bátkai(National Institutes of Health), N. Klymiuk(TUM Klinikum), Tilman Ziegler(TUM Klinikum), Stefan Engelhardt(Heidelberg University), Rainer Kozlik‐Feldmann(University Children's Hospital Tübingen), Markus Sperandio(Ludwig-Maximilians-Universität München), Nadja Hornaschewitz(TUM Klinikum), Karl‐Ludwig Laugwitz(Health First), Christian Weber(Munich Cluster for Systems Neurology), Sarah Straub(TUM Klinikum), Franz Freudenthal(Centro de Información y Desarrollo de la Mujer), Janika Viereck(Medizinische Hochschule Hannover), Tobias Borchert
Cited by 83
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
|New England Journal of Medicine|2010|1.2k
Cardiac fibroblast–derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
|Journal of Clinical Investigation|2014|993
MicroRNAs in the Human Heart
|Circulation|2007|888
Progressive hypertrophy and heart failure in β <sub>1</sub> -adrenergic receptor transgenic mice
|Proceedings of the National Academy of Sciences|1999|787